2011
DOI: 10.3390/molecules161210093
|View full text |Cite
|
Sign up to set email alerts
|

Snailase Preparation of Ginsenoside M1 from Protopanaxadiol-Type Ginsenoside and Their Protective Effects Against CCl4-Induced Chronic Hepatotoxicity in Mice

Abstract: To investigate the protective effects of protopanaxadiol-type ginsenoside (PDG) and its metabolite ginsenoside M1 (G-M1) on carbon tetrachloride (CCl4)-induced chronic liver injury in ICR mice, we carried out conversion of protopanaxadiol-type ginsenosides to ginsenoside M1 using snailase. The optimum time for the conversion was 24 h at a constant pH of 4.5 and an optimum temperature of 50 °C. The transformation products were identified by high-performance liquid chromatography and electrospray ion-mass spectr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 26 publications
0
12
0
Order By: Relevance
“…It consists of ginsenosides, polysaccharides, polyynes, flavonoids, and volatile oils among other components [2] . Ginsenosides are considered the major active components of ginseng species and are responsible for numerous pharmacological properties, such as antitumor, anti-aging, blood vessel softening, anticancer, anti-inflammatory, and hepatoprotective effect activities [3] , [4] , [5] . Deglycosylated ginsenosides (minor ginsenosides Rh1, Rh2, F2, Rg3, C-K, etc.)…”
Section: Introductionmentioning
confidence: 99%
“…It consists of ginsenosides, polysaccharides, polyynes, flavonoids, and volatile oils among other components [2] . Ginsenosides are considered the major active components of ginseng species and are responsible for numerous pharmacological properties, such as antitumor, anti-aging, blood vessel softening, anticancer, anti-inflammatory, and hepatoprotective effect activities [3] , [4] , [5] . Deglycosylated ginsenosides (minor ginsenosides Rh1, Rh2, F2, Rg3, C-K, etc.)…”
Section: Introductionmentioning
confidence: 99%
“…Ginseng ( Panax ginseng , C. A. Meyer, Araliaceae) is a versatile medicinal herb used commonly in Korea, China and Japan. Two major types of ginsenoside, protopanaxadiol and protopanaxatriol, are regarded to be responsible for ginseng's pharmacological properties including antistress, anti‐inflammatory, anticarcinogenic and hepatoprotective activities [1–6]. Ginsenosides are metabolized by intestinal microflora to their active forms before they are absorbed into the blood and exert their pharmacological activities [7].…”
Section: Introductionmentioning
confidence: 99%
“…Two major types of ginsenoside, protopanaxadiol and protopanaxatriol, are regarded to be responsible for ginseng's pharmacological properties including antistress, anti-inflammatory, anticarcinogenic and hepatoprotective activities. [1][2][3][4][5][6] Ginsenosides are metabolized by intestinal microflora to their active forms before they are absorbed into the blood and exert their pharmacological activities. [7] Among the metabolites of ginsenosides, 20(S)protopanaxadiol 20-O-β-d-glucopyranoside (compound K; also known as M1), the major pharmacologically active metabolite of ginsenoside Rb1 was shown to possess a variety of biological activities.…”
Section: Introductionmentioning
confidence: 99%
“…Compound K (C-K), a minor ginsenoside, is the main pharmacologically active metabolites detected in blood after the oral administration of ginsenosides Rb1, Rb2 or Rc (Hasegawa et al 1996;Hasegawa and Uchiyama 1998;Shin et al 2005;Park et al 2013). It has been shown that C-K possesses various biological activities, such as antitumour, anti-inflammatory and hepatoprotective effect activities (Choi et al 2007;Joh et al 2011;Lee et al 2011;Li et al 2011;Chen et al 2013). However, compound K is not present in most natural ginseng plants.…”
Section: Introductionmentioning
confidence: 99%